| Jason Dean, FNP | |
|
104 Wintergreen Hill Dr, Painesville, OH 44077-5330 | |
| (440) 429-7091 | |
| Not Available |
| Full Name | Jason Dean |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 104 Wintergreen Hill Dr, Painesville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952908568 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN.CNP.0027698 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Ana Ripoll, Rector of Universitat Aut-noma de Barcelona (UAB), and Pedro Barato, President of "Organizaci-n Interprofesional del Aceite de Oliva Espa-ol", signed a research agreement to carry out an in depth study on how the intake of olive oil can work towards preventing and fighting against breast cancer.
A pioneering clinical trial is testing the effectiveness in leukemia of a small molecule that shuts down MDM2, a protein that can disable the well-known tumor suppressor p53.
The latest research on breast cancer is good news, it says that regular exercise can reduce the risk.
Progenics Pharmaceuticals, Inc. today presented preclinical findings for its humanized monoclonal antibodies against the disease-causing toxins produced by the bacterium Clostridium difficile.
A research group at Uppsala University, Sweden has developed a new responsive coating for implants used in surgery to improve their integration into bone and to prevent rejection. Neutron scattering experiments at the Institut Laue-Langevin (ILL) in Grenoble, France have shown how a protein that promotes bone growth binds to this surface and can be released in a controlled way.
› Verified 5 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Ana Ripoll, Rector of Universitat Aut-noma de Barcelona (UAB), and Pedro Barato, President of "Organizaci-n Interprofesional del Aceite de Oliva Espa-ol", signed a research agreement to carry out an in depth study on how the intake of olive oil can work towards preventing and fighting against breast cancer.
A pioneering clinical trial is testing the effectiveness in leukemia of a small molecule that shuts down MDM2, a protein that can disable the well-known tumor suppressor p53.
The latest research on breast cancer is good news, it says that regular exercise can reduce the risk.
Progenics Pharmaceuticals, Inc. today presented preclinical findings for its humanized monoclonal antibodies against the disease-causing toxins produced by the bacterium Clostridium difficile.
A research group at Uppsala University, Sweden has developed a new responsive coating for implants used in surgery to improve their integration into bone and to prevent rejection. Neutron scattering experiments at the Institut Laue-Langevin (ILL) in Grenoble, France have shown how a protein that promotes bone growth binds to this surface and can be released in a controlled way.
› Verified 5 days ago
| Entity Name | The Metrohealth System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053353896 PECOS PAC ID: 8628982949 Enrollment ID: O20031119000355 |
News Archive
Ana Ripoll, Rector of Universitat Aut-noma de Barcelona (UAB), and Pedro Barato, President of "Organizaci-n Interprofesional del Aceite de Oliva Espa-ol", signed a research agreement to carry out an in depth study on how the intake of olive oil can work towards preventing and fighting against breast cancer.
A pioneering clinical trial is testing the effectiveness in leukemia of a small molecule that shuts down MDM2, a protein that can disable the well-known tumor suppressor p53.
The latest research on breast cancer is good news, it says that regular exercise can reduce the risk.
Progenics Pharmaceuticals, Inc. today presented preclinical findings for its humanized monoclonal antibodies against the disease-causing toxins produced by the bacterium Clostridium difficile.
A research group at Uppsala University, Sweden has developed a new responsive coating for implants used in surgery to improve their integration into bone and to prevent rejection. Neutron scattering experiments at the Institut Laue-Langevin (ILL) in Grenoble, France have shown how a protein that promotes bone growth binds to this surface and can be released in a controlled way.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Dean, FNP 104 Wintergreen Hill Dr, Painesville, OH 44077-5330 Ph: (440) 429-7091 | Jason Dean, FNP 104 Wintergreen Hill Dr, Painesville, OH 44077-5330 Ph: (440) 429-7091 |
News Archive
Ana Ripoll, Rector of Universitat Aut-noma de Barcelona (UAB), and Pedro Barato, President of "Organizaci-n Interprofesional del Aceite de Oliva Espa-ol", signed a research agreement to carry out an in depth study on how the intake of olive oil can work towards preventing and fighting against breast cancer.
A pioneering clinical trial is testing the effectiveness in leukemia of a small molecule that shuts down MDM2, a protein that can disable the well-known tumor suppressor p53.
The latest research on breast cancer is good news, it says that regular exercise can reduce the risk.
Progenics Pharmaceuticals, Inc. today presented preclinical findings for its humanized monoclonal antibodies against the disease-causing toxins produced by the bacterium Clostridium difficile.
A research group at Uppsala University, Sweden has developed a new responsive coating for implants used in surgery to improve their integration into bone and to prevent rejection. Neutron scattering experiments at the Institut Laue-Langevin (ILL) in Grenoble, France have shown how a protein that promotes bone growth binds to this surface and can be released in a controlled way.
› Verified 5 days ago
Donna Sheahan, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 236 Ardmore Blvd, Painesville, OH 44077 Phone: 440-289-3162 | |
Mrs. Nancy Rigden, NEONATAL NURSE PRACT Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 E Washington St, Painesville, OH 44077 Phone: 440-354-2400 | |
Ms. Margaret Ellen Henning, MSN, RN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1506 Mentor Ave, Painesville, OH 44077 Phone: 866-389-2727 | |
David Huffman, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7220 S Kipling Pl, Painesville, OH 44077 Phone: 216-408-4104 | |
Patricia Kelly, C.N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7580 Auburn Rd, Suite 202, Painesville, OH 44077 Phone: 440-352-0400 Fax: 440-352-4535 | |
Trisha Laska, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1506 Mentor Ave, Painesville, OH 44077 Phone: 440-354-5609 | |
Ms. Georgia Zinsser Saltzman, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 462 Chardon St, Painesville, OH 44077 Phone: 440-853-1501 |